{"id":29347,"date":"2024-12-16T11:40:42","date_gmt":"2024-12-16T10:40:42","guid":{"rendered":"https:\/\/ggba.swiss\/western-switzerland-healthcare-start-ups-limula-actival-and-aircurve-secure-fit-funding\/"},"modified":"2024-12-16T11:44:00","modified_gmt":"2024-12-16T10:44:00","slug":"limula-actival-et-aircurve-obtiennent-un-financement-de-la-fit","status":"publish","type":"post","link":"https:\/\/ggba.swiss\/fr\/limula-actival-et-aircurve-obtiennent-un-financement-de-la-fit\/","title":{"rendered":"Limula, Actival et AirCurve obtiennent un financement de la FIT"},"content":{"rendered":"\n<p>La Fondation pour l&rsquo;innovation et la technologie (<a href=\"https:\/\/www.fondation-fit.ch\/\">FIT<\/a>) a annonc\u00e9 son dernier cycle de financement, soutenant trois start-ups de Suisse occidentale qui font progresser les soins de sant\u00e9 et la technologie m\u00e9dicale. Ces projets s&rsquo;attaquent \u00e0 des probl\u00e8mes cruciaux dans les domaines de la fabrication de th\u00e9rapies cellulaires, de la sant\u00e9 dentaire et de la gestion des voies respiratoires, renfor\u00e7ant ainsi la position de la r\u00e9gion en tant que plaque tournante de l&rsquo;innovation.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\">Limula : rendre les th\u00e9rapies cellulaires plus accessibles<\/h4>\n\n\n\n<p><a href=\"https:\/\/limula.ch\/\">Limula<\/a> vise \u00e0 transformer la production de th\u00e9rapies cellulaires et g\u00e9niques, qui sont essentielles pour traiter les cancers et d&rsquo;autres maladies incurables. Ces th\u00e9rapies, produites \u00e0 partir du sang du patient, sont confront\u00e9es \u00e0 des difficult\u00e9s li\u00e9es \u00e0 des m\u00e9thodes de production complexes et co\u00fbteuses. La technologie brevet\u00e9e de Limula automatise le processus au sein d&rsquo;une seule machine, r\u00e9duisant les \u00e9tapes manuelles et les risques de contamination, et permettant une production d\u00e9centralis\u00e9e.<\/p>\n\n\n\n<p>Gr\u00e2ce \u00e0 un pr\u00eat Tech Growth de CHF 500&rsquo;000 de la FIT, Limula d\u00e9veloppera quatre prototypes avanc\u00e9s qui seront test\u00e9s par des partenaires en 2025 et renforcera son \u00e9quipe pour soutenir ces premiers utilisateurs. Il s&rsquo;agit de la troisi\u00e8me \u00e9tape soutenue par la FIT pour Limula, apr\u00e8s les financements pr\u00e9c\u00e9dents de 2019 et 2022.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\">Actival : des goutti\u00e8res dentaires actives pour une meilleure sant\u00e9 bucco-dentaire<\/h4>\n\n\n\n<p><a href=\"https:\/\/activ-al.com\/\">Actival<\/a> a mis au point une nouvelle g\u00e9n\u00e9ration de goutti\u00e8res dentaires con\u00e7ues pour lutter contre les probl\u00e8mes courants tels que l&rsquo;accumulation de plaque dentaire, les taches blanches et les caries caus\u00e9es par un port prolong\u00e9. Dot\u00e9es de microcanaux brevet\u00e9s, ces goutti\u00e8res lib\u00e8rent lentement des agents antibact\u00e9riens, du fluor et des ar\u00f4mes pendant dix jours, am\u00e9liorant ainsi la sant\u00e9 des dents et des gencives.<\/p>\n\n\n\n<p>Un pr\u00eat de CHF 100&rsquo;000 de la FIT permettra \u00e0 Actival d&rsquo;optimiser la conception de ses microcanaux et de fabriquer des prototypes, se rapprochant ainsi de la mise sur le march\u00e9.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\">AirCurve : intubation robotis\u00e9e guid\u00e9e par l&rsquo;IA pour des proc\u00e9dures plus s\u00fbres<\/h4>\n\n\n\n<p><a href=\"https:\/\/www.aircurve-medical.com\/\">AirCurve<\/a>, en collaboration avec l&rsquo;EPFL et le CHUV, introduit un syst\u00e8me robotique d&rsquo;intubation trach\u00e9ale guid\u00e9 par l&rsquo;IA afin d&rsquo;am\u00e9liorer la s\u00e9curit\u00e9 et la pr\u00e9cision dans les h\u00f4pitaux et les services d&rsquo;urgence. Avec un taux de complication estim\u00e9 \u00e0 15% sur les 100 millions d&rsquo;intubations r\u00e9alis\u00e9es chaque ann\u00e9e, la technologie d&rsquo;AirCurve vise \u00e0 r\u00e9duire les erreurs et \u00e0 garantir de meilleurs r\u00e9sultats. Le pr\u00eat Tech Seed de CHF 100&rsquo;000 financera le mat\u00e9riel n\u00e9cessaire pour faire progresser le syst\u00e8me au-del\u00e0 du stade du prototype, en int\u00e9grant les commentaires des professionnels de la sant\u00e9 pour affiner sa conception.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Limula, Actival et AirCurve ont re\u00e7u un financement de la FIT pour faire \u00e9voluer des solutions r\u00e9volutionnaires dans la production de th\u00e9rapies cellulaires, la sant\u00e9 dentaire et l&rsquo;intubation trach\u00e9ale. Limula a obtenu un pr\u00eat Tech Growth de CHF 500&rsquo;000, tandis qu&rsquo;Actival et AirCurve ont re\u00e7u chacun un pr\u00eat Tech Seed de CHF 100&rsquo;000.<\/p>\n","protected":false},"author":6,"featured_media":29344,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[843],"tags":[1179,1180,1148,1188,1181,1163,1140],"class_list":["post-29347","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sciences-de-la-vie","tag-artificial-intelligence-fr-2","tag-digital-health-fr-2","tag-financing-fr-2","tag-healthcare-fr-2","tag-medical-devices-fr","tag-medtech-fr-2","tag-oncology-fr-2"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Limula, Actival et AirCurve obtiennent un financement de la FIT<\/title>\n<meta name=\"description\" content=\"Limula, Actival et AirCurve ont re\u00e7u un financement de la FIT pour faire \u00e9voluer leurs solutions r\u00e9volutionnaires.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ggba.swiss\/fr\/limula-actival-et-aircurve-obtiennent-un-financement-de-la-fit\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Limula, Actival et AirCurve obtiennent un financement de la FIT\" \/>\n<meta property=\"og:description\" content=\"Limula, Actival et AirCurve ont re\u00e7u un financement de la FIT pour faire \u00e9voluer leurs solutions r\u00e9volutionnaires.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ggba.swiss\/fr\/limula-actival-et-aircurve-obtiennent-un-financement-de-la-fit\/\" \/>\n<meta property=\"og:site_name\" content=\"Greater Geneva Bern area\" \/>\n<meta property=\"article:published_time\" content=\"2024-12-16T10:40:42+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-12-16T10:44:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ggba.swiss\/app\/uploads\/2024\/12\/Limula-Scan-1180x811-v2.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"1180\" \/>\n\t<meta property=\"og:image:height\" content=\"811\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Pierre-Yves Oehrli\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Pierre-Yves Oehrli\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ggba.swiss\/fr\/limula-actival-et-aircurve-obtiennent-un-financement-de-la-fit\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/limula-actival-et-aircurve-obtiennent-un-financement-de-la-fit\/\"},\"author\":{\"name\":\"Pierre-Yves Oehrli\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"headline\":\"Limula, Actival et AirCurve obtiennent un financement de la FIT\",\"datePublished\":\"2024-12-16T10:40:42+00:00\",\"dateModified\":\"2024-12-16T10:44:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/limula-actival-et-aircurve-obtiennent-un-financement-de-la-fit\/\"},\"wordCount\":486,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/limula-actival-et-aircurve-obtiennent-un-financement-de-la-fit\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/12\/Limula-Scan-1180x811-v2.jpeg\",\"keywords\":[\"Artificial Intelligence\",\"Digital Health\",\"Financing\",\"Healthcare\",\"Medical Devices\",\"Medtech\",\"Oncology\"],\"articleSection\":[\"Sciences de la vie\"],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/ggba.swiss\/fr\/limula-actival-et-aircurve-obtiennent-un-financement-de-la-fit\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ggba.swiss\/fr\/limula-actival-et-aircurve-obtiennent-un-financement-de-la-fit\/\",\"url\":\"https:\/\/ggba.swiss\/fr\/limula-actival-et-aircurve-obtiennent-un-financement-de-la-fit\/\",\"name\":\"Limula, Actival et AirCurve obtiennent un financement de la FIT\",\"isPartOf\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/limula-actival-et-aircurve-obtiennent-un-financement-de-la-fit\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/limula-actival-et-aircurve-obtiennent-un-financement-de-la-fit\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/12\/Limula-Scan-1180x811-v2.jpeg\",\"datePublished\":\"2024-12-16T10:40:42+00:00\",\"dateModified\":\"2024-12-16T10:44:00+00:00\",\"author\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"description\":\"Limula, Actival et AirCurve ont re\u00e7u un financement de la FIT pour faire \u00e9voluer leurs solutions r\u00e9volutionnaires.\",\"breadcrumb\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/limula-actival-et-aircurve-obtiennent-un-financement-de-la-fit\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ggba.swiss\/fr\/limula-actival-et-aircurve-obtiennent-un-financement-de-la-fit\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ggba.swiss\/fr\/limula-actival-et-aircurve-obtiennent-un-financement-de-la-fit\/#primaryimage\",\"url\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/12\/Limula-Scan-1180x811-v2.jpeg\",\"contentUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/12\/Limula-Scan-1180x811-v2.jpeg\",\"width\":1180,\"height\":811,\"caption\":\"Le scan d'un lymphocyte T (cellule T) sain met en \u00e9vidence les cellules utilis\u00e9es dans les th\u00e9rapies cellulaires, que la plateforme de fabrication automatis\u00e9e de Limula vise \u00e0 produire de mani\u00e8re plus efficace et plus accessible pour les patients. | \u00a9 NIAID CC BY 2.0.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ggba.swiss\/fr\/limula-actival-et-aircurve-obtiennent-un-financement-de-la-fit\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ggba.swiss\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Limula, Actival et AirCurve obtiennent un financement de la FIT\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\",\"url\":\"https:\/\/staging.ggba.swiss\/en\/\",\"name\":\"Greater Geneva Bern area\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\",\"name\":\"Pierre-Yves Oehrli\",\"url\":\"https:\/\/ggba.swiss\/fr\/author\/pierre-yves-oehrli\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Limula, Actival et AirCurve obtiennent un financement de la FIT","description":"Limula, Actival et AirCurve ont re\u00e7u un financement de la FIT pour faire \u00e9voluer leurs solutions r\u00e9volutionnaires.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ggba.swiss\/fr\/limula-actival-et-aircurve-obtiennent-un-financement-de-la-fit\/","og_locale":"fr_FR","og_type":"article","og_title":"Limula, Actival et AirCurve obtiennent un financement de la FIT","og_description":"Limula, Actival et AirCurve ont re\u00e7u un financement de la FIT pour faire \u00e9voluer leurs solutions r\u00e9volutionnaires.","og_url":"https:\/\/ggba.swiss\/fr\/limula-actival-et-aircurve-obtiennent-un-financement-de-la-fit\/","og_site_name":"Greater Geneva Bern area","article_published_time":"2024-12-16T10:40:42+00:00","article_modified_time":"2024-12-16T10:44:00+00:00","og_image":[{"width":1180,"height":811,"url":"https:\/\/ggba.swiss\/app\/uploads\/2024\/12\/Limula-Scan-1180x811-v2.jpeg","type":"image\/jpeg"}],"author":"Pierre-Yves Oehrli","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Pierre-Yves Oehrli","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ggba.swiss\/fr\/limula-actival-et-aircurve-obtiennent-un-financement-de-la-fit\/#article","isPartOf":{"@id":"https:\/\/ggba.swiss\/fr\/limula-actival-et-aircurve-obtiennent-un-financement-de-la-fit\/"},"author":{"name":"Pierre-Yves Oehrli","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"headline":"Limula, Actival et AirCurve obtiennent un financement de la FIT","datePublished":"2024-12-16T10:40:42+00:00","dateModified":"2024-12-16T10:44:00+00:00","mainEntityOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/limula-actival-et-aircurve-obtiennent-un-financement-de-la-fit\/"},"wordCount":486,"commentCount":0,"image":{"@id":"https:\/\/ggba.swiss\/fr\/limula-actival-et-aircurve-obtiennent-un-financement-de-la-fit\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2024\/12\/Limula-Scan-1180x811-v2.jpeg","keywords":["Artificial Intelligence","Digital Health","Financing","Healthcare","Medical Devices","Medtech","Oncology"],"articleSection":["Sciences de la vie"],"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ggba.swiss\/fr\/limula-actival-et-aircurve-obtiennent-un-financement-de-la-fit\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ggba.swiss\/fr\/limula-actival-et-aircurve-obtiennent-un-financement-de-la-fit\/","url":"https:\/\/ggba.swiss\/fr\/limula-actival-et-aircurve-obtiennent-un-financement-de-la-fit\/","name":"Limula, Actival et AirCurve obtiennent un financement de la FIT","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/limula-actival-et-aircurve-obtiennent-un-financement-de-la-fit\/#primaryimage"},"image":{"@id":"https:\/\/ggba.swiss\/fr\/limula-actival-et-aircurve-obtiennent-un-financement-de-la-fit\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2024\/12\/Limula-Scan-1180x811-v2.jpeg","datePublished":"2024-12-16T10:40:42+00:00","dateModified":"2024-12-16T10:44:00+00:00","author":{"@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"description":"Limula, Actival et AirCurve ont re\u00e7u un financement de la FIT pour faire \u00e9voluer leurs solutions r\u00e9volutionnaires.","breadcrumb":{"@id":"https:\/\/ggba.swiss\/fr\/limula-actival-et-aircurve-obtiennent-un-financement-de-la-fit\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ggba.swiss\/fr\/limula-actival-et-aircurve-obtiennent-un-financement-de-la-fit\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ggba.swiss\/fr\/limula-actival-et-aircurve-obtiennent-un-financement-de-la-fit\/#primaryimage","url":"https:\/\/ggba.swiss\/app\/uploads\/2024\/12\/Limula-Scan-1180x811-v2.jpeg","contentUrl":"https:\/\/ggba.swiss\/app\/uploads\/2024\/12\/Limula-Scan-1180x811-v2.jpeg","width":1180,"height":811,"caption":"Le scan d'un lymphocyte T (cellule T) sain met en \u00e9vidence les cellules utilis\u00e9es dans les th\u00e9rapies cellulaires, que la plateforme de fabrication automatis\u00e9e de Limula vise \u00e0 produire de mani\u00e8re plus efficace et plus accessible pour les patients. | \u00a9 NIAID CC BY 2.0."},{"@type":"BreadcrumbList","@id":"https:\/\/ggba.swiss\/fr\/limula-actival-et-aircurve-obtiennent-un-financement-de-la-fit\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ggba.swiss\/fr\/"},{"@type":"ListItem","position":2,"name":"Limula, Actival et AirCurve obtiennent un financement de la FIT"}]},{"@type":"WebSite","@id":"https:\/\/staging.ggba.swiss\/en\/#website","url":"https:\/\/staging.ggba.swiss\/en\/","name":"Greater Geneva Bern area","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41","name":"Pierre-Yves Oehrli","url":"https:\/\/ggba.swiss\/fr\/author\/pierre-yves-oehrli\/"}]}},"_links":{"self":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/29347","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/comments?post=29347"}],"version-history":[{"count":1,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/29347\/revisions"}],"predecessor-version":[{"id":29349,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/29347\/revisions\/29349"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media\/29344"}],"wp:attachment":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media?parent=29347"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/categories?post=29347"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/tags?post=29347"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}